DALLAS BURSTON HEALTHCARE LIMITED

BUDESONEBS

pharmaceutical preparations and substances;

BUDESONEBS

pharmaceutical preparations and substances for the treatment of respiratory asthmatic conditions and for use in inhalers, nebulizers or respirators;

CROMONEBS

pharmaceutical preparations and substances for the treatment of respiratory or asthmatic conditions or for use in inhalers, nebulisers or respirators;

IPRANEBS

pharmaceutical preparation and substances containing Ipratropium for the treatment of respiratory and asthmatic conditions;

IPRANEBS

pharmaceutical preparations and substances;

ISIB

pharmaceutical preparations and substances for the treatment of cerebrovascular, cardiovascular and/or ischemic conditions;

MONOISOTARD

pharmaceutical preparations and substances containing isosorbide mononitrate for the treatment of cardiovascular and/or ischemic conditions;

POST-C.V.A.

aspirin-based pharmaceuticals and substances for oral consumption or subcutaneous use, to ameliorate cardiovascular trauma;

POST-T.I.A.

pharmaceutical preparations and substances; all for oral consumption or subcutaneous use;

POSTMI

pharmaceutical preparations and substances, namely, aspirin based preparations for the treatment of cardiovascular conditions;

PRE-C.V.A.

aspirin-based pharmaceuticals and substances for oral consumption or subcutaneous use, as prophylaxis for cerebro-cardiovascular trauma;

PRE-MI

pharmaceutical preparations and substances, namely, aspirin based preparations for the treatment of cardiovascular conditions;PRE MI;

PRETIA

oral and subcutaneous pharmaceutical preparations used to treat transient ischemic attack;

REMEGESIC

pharmaceutical preparations, namely, analgesics, painkillers, and pain suppressants;

SALBUNEBS

pharmaceutical preparations and substances, namely, salbutamol used to treat respiratory and asthmatic conditions;

TYLOGESIC

pharmaceutical preparations and substances;